BIOMAT Database Logo BIOMAT Database Logo

Inhibition of simian virus 40 replication by kanamycin derivative. 1986

H Yamaki, and N Tanaka, and H Ariga

UI MeSH Term Description Entries
D007612 Kanamycin Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. Kanamycin A,Kanamycin Sulfate,Kantrex
D009856 Oncogene Proteins, Viral Products of viral oncogenes, most commonly retroviral oncogenes. They usually have transforming and often protein kinase activities. Viral Oncogene Proteins,Viral Transforming Proteins,v-onc Proteins,Transforming Proteins, Viral,v onc Proteins
D004261 DNA Replication The process by which a DNA molecule is duplicated. Autonomous Replication,Replication, Autonomous,Autonomous Replications,DNA Replications,Replication, DNA,Replications, Autonomous,Replications, DNA
D000952 Antigens, Polyomavirus Transforming Polyomavirus antigens which cause infection and cellular transformation. The large T antigen is necessary for the initiation of viral DNA synthesis, repression of transcription of the early region and is responsible in conjunction with the middle T antigen for the transformation of primary cells. Small T antigen is necessary for the completion of the productive infection cycle. Polyomavirus Large T Antigens,Polyomavirus Middle T Antigens,Polyomavirus Small T Antigens,Polyomavirus T Proteins,Polyomavirus Transforming Antigens,Polyomavirus Tumor Antigens,SV40 T Antigens,SV40 T Proteins,Simian Sarcoma Virus Proteins,Polyomaviruses Large T Proteins,Polyomaviruses Middle T Proteins,Polyomaviruses Small T Proteins,Antigens, Polyomavirus Tumor,Antigens, SV40 T,Proteins, Polyomavirus T,Proteins, SV40 T,T Antigens, SV40,T Proteins, Polyomavirus,T Proteins, SV40,Transforming Antigens, Polyomavirus,Tumor Antigens, Polyomavirus
D000957 Antigens, Viral, Tumor Those proteins recognized by antibodies from serum of animals bearing tumors induced by viruses; these proteins are presumably coded for by the nucleic acids of the same viruses that caused the neoplastic transformation. Antigens, Neoplasm, Viral,Neoplasm Antigens, Viral,T Antigens,Tumor Antigens, Viral,Viral Tumor Antigens,Virus Transforming Antigens,Large T Antigen,Large T-Antigen,Small T Antigen,Small T-Antigen,T Antigen,T-Antigen,Viral T Antigens,Antigen, Large T,Antigen, Small T,Antigen, T,Antigens, T,Antigens, Viral Neoplasm,Antigens, Viral T,Antigens, Viral Tumor,Antigens, Virus Transforming,T Antigen, Large,T Antigen, Small,T Antigens, Viral,T-Antigen, Large,T-Antigen, Small,Transforming Antigens, Virus,Viral Neoplasm Antigens
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013539 Simian virus 40 A species of POLYOMAVIRUS originally isolated from Rhesus monkey kidney tissue. It produces malignancy in human and newborn hamster kidney cell cultures. SV40 Virus,Vacuolating Agent,Polyomavirus macacae,SV 40 Virus,SV 40 Viruses,SV40 Viruses,Vacuolating Agents
D014158 Transcription, Genetic The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION. Genetic Transcription
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications

Related Publications

H Yamaki, and N Tanaka, and H Ariga
Inhibition of influenza A virus replication by a kanamycin derivative.
January 1991, Antiviral research,
H Yamaki, and N Tanaka, and H Ariga
Inhibition of simian virus 40 DNA replication by ultraviolet light.
July 1983, Virology,
H Yamaki, and N Tanaka, and H Ariga
Novobiocin inhibition of simian virus 40 DNA replication.
July 1980, Nature,
H Yamaki, and N Tanaka, and H Ariga
Inhibition of DNA replication of adenovirus type 5 and simian virus 40 by tunicamycin.
June 1991, Virology,
H Yamaki, and N Tanaka, and H Ariga
Inhibition of simian virus 40 replication by interferon treatment late in the lytic cycle.
July 1977, Virology,
H Yamaki, and N Tanaka, and H Ariga
Bidirectional replication of Simian Virus 40 DNA.
November 1972, Proceedings of the National Academy of Sciences of the United States of America,
H Yamaki, and N Tanaka, and H Ariga
Simian virus 40 DNA replication in vitro.
November 1984, Proceedings of the National Academy of Sciences of the United States of America,
H Yamaki, and N Tanaka, and H Ariga
Structural topography of simian virus 40 DNA replication.
May 1991, Journal of virology,
H Yamaki, and N Tanaka, and H Ariga
Replication and structure of simian virus 40 chromosomes.
January 1979, Cold Spring Harbor symposia on quantitative biology,
H Yamaki, and N Tanaka, and H Ariga
Inhibition of simian virus 40 DNA replication by specific modification of T-antigen with oxidized ATP.
November 1986, The Journal of biological chemistry,
Copied contents to your clipboard!